Cite
HARVARD Citation
Aluwini, S. et al. (n.d.). Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Lancet oncology. 16 (3), pp. 274-283. [Online].